Add to my selection

ONIVYDE (chlorhydrate d’irinotécan trihydrate liposomal pégylé)

Medicine - Posted on Jun 30 2025

Active substance (DCI)

irinotécan liposomal pégylé

history (2)

6/11/25

ONIVYDE PEGYLATED LIPOSOMAL (pegylated liposomal irinotecan) - Metastatic adenocarcinoma of the pancreas

Summary of opinion Favourable opinion for reimbursement of ONIVYDE PEGYLATED LIPOSOMAL “in combination with oxaliplatin, 5-f...

CAV :
54321

icône flèche
4/19/17

ONIVYDE (pegylated liposomal irinotecan), antineoplastic agent

No clinical benefit demonstrated in the treatment of metastatic pancreatic adenocarcinoma. ONIVYDE has marketing authorisati...

CAV :
54321

icône flèche

Technical information

ATC code

L01CE02

Manufacturer

LES LABORATOIRES SERVIER

Presentation

ONIVYDE 5 mg/ml, solution à diluer pour perfusion (code CIS : 63390752)
1 flacon en verre de 10 ml (CIP : 34009 300 741 5 2)

All our publications

Digestive system cancers